Myelosupression induced by linezolid: a pediatric case

Archivos argentinos de pediatría
María Del M Ballesteros GarcíaPilar Galán Del Río

Abstract

Linezolid is an antibiotic of oxazolidinones family that inhibits proteical synthesis. It is used in several Gram-positive multirresistent infections. Its more frequent side effects are gastrointestinal, followed by peripheral neuropathy and myelosuppression. We report the case of a 12-year-old boy diagnosed with septic osteoarthritis of the hip and femoral osteomyelitis, following treatment with linezolid, who complained about digestive intolerance and weight loss. He showed severe normocytic anemia and mild leukopenia and thrombocytopenia with data of hematopoiesis disorder in the blood smear that suggested drug toxicity. These findings reverted when the treatment was discontinued. Reversible myelosuppression associated with linezolid is related to long treatments (more than 28 days). So it is necessary to check the blood count during long treatments.

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Related Papers

Medicina clínica
María José Menéndez CalderónPatricia Bueno
American Journal of Therapeutics
Venugopalan Y VishnuVivek Lal
JAMA : the Journal of the American Medical Association
P A AbenaB C Vandercam
JAMA : the Journal of the American Medical Association
M C Lawyer, E Z Lawyer
JAMA : the Journal of the American Medical Association
Felix M Arellano
© 2022 Meta ULC. All rights reserved